Top Markets
#1 ADO Protocol ADO Protocol +195.10%
#2 Islamic Coin Islamic Coin +155.35%
#3 GoPlus Security GoPlus Security +54.44%
#4 GAIB AID GAIB AID +24.67%
#5 Starpower Starpower +22.00%
#6 Verus Coin Verus Coin +13.54%
#7 Tutorial Tutorial +12.72%
#8 Casper Network Casper Network +12.03%
#9 SkyAI SkyAI +11.78%
#10 Pons Pons +11.75%
Coin of the day
ADO Protocol ADO Protocol
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Rankning i aktier #33463
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Aktiekurs
$0.5099
Senast synkroniserad: 2024-10-15
Marknadsvärde
$7.60M
Förändring (1 dag)
2.02%
Förändring (1 år)
0.00%
Land
US
Handel Anew Medical, Inc. (WENA)

Kategori

Healthcare
Vinst för Anew Medical, Inc. (WENA)
Vinst i Jun 2024 TTM: $114.12K
Enligt de senaste finansiella rapporterna från Anew Medical, Inc. är företagets nuvarande vinst $114.12K. År 2022 hade företaget en vinst på $1.56M, en ökning jämfört med vinsten år 2021 som var $-1.11M. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Anew Medical, Inc. från 2021 till 2026
Vinst vid slutet av varje år
År Vinst Ändra
2026 (TTM) $114.12K -94.40%
2023 $2.04M 30.95%
2022 $1.56M -240.25%
2021 $-1.11M 0.00%
Vinst för liknande företag eller konkurrenter
Företag Vinst Skillnad i vinst Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B 4,622,261.26%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B 1,709,242.25%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B 2,633,790.84%
BE